Diagnosis and management of low-grade dysplasia in Barrett's esophagus: expert review from the Clinical Practice Updates Committee of the American …

S Wani, JH Rubenstein, M Vieth, J Bergman - Gastroenterology, 2016 - Elsevier
The purpose of this clinical practice update expert review is to define the key principles in
the diagnosis and management of low-grade dysplasia (LGD) in Barrett's esophagus …

Diagnosis and management of Barrett's esophagus: an updated ACG guideline

NJ Shaheen, GW Falk, PG Iyer, RF Souza… - Official journal of the …, 2022 - journals.lww.com
Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Barrett's esophagus: diagnosis and management

S Eluri, NJ Shaheen - Gastrointestinal endoscopy, 2017 - giejournal.org
Barrett's esophagus (BE) is characterized by a change of the normal stratified squamous
epithelium lining the esophagus to a metaplastic columnar epithelium with goblet cells. The …

Endoscopic eradication therapy for patients with Barrett's esophagus–associated dysplasia and intramucosal cancer

S Wani, B Qumseya, S Sultan, D Agrawal… - Gastrointestinal …, 2018 - giejournal.org
Barrett's esophagus (BE) is defined by the replacement of the normal squamous epithelium
of the distal esophagus with metaplastic intestinal-type columnar epithelium. 1-3 BE is an …

Late recurrence of Barrett's esophagus after complete eradication of intestinal metaplasia is rare: final report from ablation in intestinal metaplasia containing dysplasia …

CC Cotton, WA Wolf, BF Overholt, N Li, CJ Lightdale… - Gastroenterology, 2017 - Elsevier
Background & Aims The goal of treatment for Barrett's esophagus (BE) with dysplasia is
complete eradication of intestinal metaplasia (CEIM). The long-term durability of CEIM has …

Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study

SS Sami, A Ravindran, A Kahn, D Snyder, J Santiago… - Gut, 2019 - gut.bmj.com
Objective Surveillance interval protocols after complete remission of intestinal metaplasia
(CRIM) post radiofrequency ablation (RFA) in Barrett's oesophagus (BE) are currently …

S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

A Madisch, H Koop, S Miehlke, J Leers… - Zeitschrift für …, 2023 - thieme-connect.com
Die gastroösophageale Refluxkrankheit gehört zur häufigsten organischen
Oberbaucherkrankung. Zwar hat eine Klasse von Säurehemmern …

A general strategy for batch development of high-performance and cost-effective sodium layered cathodes

B Xiao, X Liu, M Song, X Yang, F Omenya, S Feng… - Nano Energy, 2021 - Elsevier
High-performance and low-cost transition metal (TM) layered oxides using earth abundant
elements are promising cathodes for Na-ion batteries. However, it is challenging to obtain …

Hybrid APC in combination with resection for the endoscopic treatment of neoplastic Barrett's esophagus: a prospective, multicenter study

M Knabe, T Beyna, T Rösch, J Bergman… - Official journal of the …, 2022 - journals.lww.com
METHODS: Consecutive patients with neoplastic BE undergoing ablation after curative
endoscopic resection (89.6%) or primarily were included into this prospective trial in 9 …

Recurrence of Barrett's esophagus is rare following endoscopic eradication therapy coupled with effective reflux control

S Komanduri, PJ Kahrilas, K Krishnan… - Official journal of the …, 2017 - journals.lww.com
Objectives: Recent data suggest that effective control of gastroesophageal reflux improves
outcomes associated with endoscopic eradication therapy (EET) for Barrett's esophagus …